Double or triple down: how AFT Pharmaceuticals plans to win in China

Double or triple down: how AFT Pharmaceuticals plans to win in China
(Image: Getty)
Rebecca Stevenson
AFT Pharmaceuticals says it has increased manufacturing capacity and brought in market experts as it prepares to launch its antibacterial cream in China. The New Zealand Exchange-listed (NZX) firm reported its results for the 12 months to March 31 on May 23. Its international and Asian sales rose 70%, accounting for 20% of revenue. Operating revenue for AFT’s Asian business grew 57% to $10.7 million from $6.8m, while operating profit rose to $2.5m from $900,000.It said growth was driven through the hospital channel, wi...

More Markets

NZ sharemarket lifts off after Auckland Airport numbers
Markets Market close

NZ sharemarket lifts off after Auckland Airport numbers

The S&P/NZX 50 Index closed at 12,943.57, gaining 59.19 points or 0.46%.

Graham Skellern 15 Jan 2025
Auckland Airport numbers bounce back
Markets

Auckland Airport numbers bounce back

Numbers highest since the pandemic hit five years ago.

Staff reporters 15 Jan 2025
NZD outlook: 2025 more about surviving
Markets

NZD outlook: 2025 more about surviving

The kiwi shed more than 11% in 2024, and we already see more downsides. 

Rebecca Howard 15 Jan 2025
Rate decision odds are tight, NZD set for a wild ride
Markets Best of BusinessDesk

Rate decision odds are tight, NZD set for a wild ride

It did turn out to be an understatement. 

Rebecca Howard 15 Jan 2025